Lacktman Quoted on New Telemedicine Laws in Oklahoma, Texas
August 2, 2017
Bloomberg BNA
Partner Nate Lacktman was quoted in a Bloomberg BNA article, “New State Telemedicine Laws Show Provider Hurdles Remain,” covering the pros and cons of the new telemedicine laws in Oklahoma and Texas, and the evolution of telemedicine as a whole.
Lacktman said, “Although there is relative consistency and homogeneity in how state laws define the ‘practice of medicine,’ state law definitions of telemedicine are varied, as are state telemedicine practice standards. Telemedicine providers would benefit if state legislatures and medical boards used consistent definitions, such as the model language contained in the Federation of State Medical Boards’ [Model Policy for the Appropriate Use of Telemedicine Technologies].”
“There is an evolution at play for telemedicine regulation,” he continued later. “When we started, most states had no telemedicine rules, and providers asked for laws that affirmatively stated ‘yes, you may use telemedicine.’ A decade later, providers are asking to make those same rules less onerous and more flexible.”
Lacktman said, “Although there is relative consistency and homogeneity in how state laws define the ‘practice of medicine,’ state law definitions of telemedicine are varied, as are state telemedicine practice standards. Telemedicine providers would benefit if state legislatures and medical boards used consistent definitions, such as the model language contained in the Federation of State Medical Boards’ [Model Policy for the Appropriate Use of Telemedicine Technologies].”
“There is an evolution at play for telemedicine regulation,” he continued later. “When we started, most states had no telemedicine rules, and providers asked for laws that affirmatively stated ‘yes, you may use telemedicine.’ A decade later, providers are asking to make those same rules less onerous and more flexible.”
People
Related News
January 6, 2026
In the News
Kyle Faget Weighs in on Pharmaceutical Industry Legal Battles
Foley & Lardner LLP partner Kyle Faget shared insight with Law360 on major legal topics affecting the pharmaceutical industry.
January 2, 2026
In the News
Judith Waltz Shares Insights on Key Health Law Developments on AHLA Podcast
Foley & Lardner LLP partner Judith Waltz hosted the American Health Law Association's Speaking of Health Law podcast to discuss major health law developments from 2025 and offer insights on trends expected in 2026.
January 2, 2026
In the News
Rajiv Dharnidharka Examines Trade Secret Litigation Trends
Foley & Lardner LLP partner Rajiv Dharnidharka commented on anticipated developments in trade secret law this year in the Law360 article, “Trade Secret Trends To Watch In 2026.”